Cumberland Pharmaceuticals Inc Asset Turnover Ratio (CPIX), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cumberland Pharmaceuticals Inc   (NASDAQ: CPIX)
 

Cumberland Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cumberland Pharmaceuticals Inc 's asset turnover ratio, the ratio that measures the ability of Cumberland Pharmaceuticals Inc 's assets to generate revenue, sequentially decreased to 0.45 in the second quarter (Jun 30 2026), but it does not raise any concerns as Cumberland Pharmaceuticals Inc continue to execute well, and the asset turnover ratio remains above the average.

Within sector 85 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 1761, from total ranking in the first quarter 2025 at 1864.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CPIX Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change -7.4 % 1.51 % 7.27 % -8.32 % -8.59 %
Y / Y Revenue Change -98.46 % -22.04 % 31.08 % -8.73 % 10.04 %
Asset Turnover Ratio (TTM) 0.45 0.6 0.63 0.6 0.6
CPIX's Total Ranking # 1761 # 1864 # 1819 # 1879 # 1995
Seq. Asset Change -11.43 % -7.59 % 16.58 % -2.96 % -2.9 %
Seq. Revenue Change -98.18 % -33.24 % 64.95 % -23.48 % -7.48 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 86
Healthcare Sector # 315
Overall Market # 1761

Asset Turnover Ratio Statistics
High Average Low
0.63 0.43 0.33
(Dec 31 2025)   (Mar 31 2014)




CPIX Company Profile • Back to CPIX Efficiency Comparisons • Compare CPIX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Idexx Laboratories Inc  1.34 $ 4,553.792  Millions$ 3,391.326  Millions
Vaxart Inc   1.31 $ 243.064  Millions$ 185.077  Millions
Karyopharm Therapeutics Inc   1.31 $ 146.621  Millions$ 111.845  Millions
Aveanna Healthcare Holdings Inc   1.31 $ 2,602.820  Millions$ 1,987.815  Millions
Tactile Systems Technology Inc   1.29 $ 350.319  Millions$ 271.226  Millions
Lifeloc Technologies Inc   1.29 $ 9.269  Millions$ 7.201  Millions
Precipio inc   1.29 $ 27.198  Millions$ 21.149  Millions
Interpace Biosciences Inc   1.28 $ 36.519  Millions$ 28.458  Millions
Exagen Inc   1.27 $ 71.427  Millions$ 56.184  Millions
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions
Rockwell Medical inc   1.22 $ 69.827  Millions$ 57.145  Millions
Ardent Health Inc   1.22 $ 6,405.940  Millions$ 5,244.371  Millions
Docgo Inc   1.22 $ 294.721  Millions$ 241.732  Millions
Henry Schein Inc   1.21 $ 13,602.000  Millions$ 11,249.250  Millions
Inogen Inc   1.20 $ 354.304  Millions$ 294.283  Millions
Nuwellis Inc   1.19 $ 9.013  Millions$ 7.547  Millions
Angiodynamics Inc   1.18 $ 317.726  Millions$ 268.407  Millions
Myriad Genetics Inc   1.17 $ 805.900  Millions$ 686.825  Millions
Universal Health Services Inc   1.16 $ 18,114.487  Millions$ 15,622.036  Millions
Polomar Health Services, Inc.  1.15 $ 3.172  Millions$ 2.748  Millions
Sunshine Biopharma Inc   1.15 $ 35.347  Millions$ 30.782  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  1.15 $ 25.185  Millions$ 21.950  Millions
Natera Inc   1.14 $ 2,707.077  Millions$ 2,372.930  Millions
Arbutus Biopharma Corp  1.14 $ 181.720  Millions$ 159.361  Millions
Elite Pharmaceuticals Inc   1.14 $ 140.130  Millions$ 122.899  Millions
Mettler toledo International Inc   1.13 $ 4,133.875  Millions$ 3,643.493  Millions
Mimedx Group Inc   1.13 $ 354.086  Millions$ 312.829  Millions
Cue Biopharma Inc   1.11 $ 37.654  Millions$ 33.860  Millions
Axsome Therapeutics Inc   1.10 $ 776.569  Millions$ 708.527  Millions
Treace Medical Concepts Inc   1.09 $ 205.307  Millions$ 188.082  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.